Recombinant human erythropoietin in combined treatment with granulocyte- or granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes.

PubWeight™: 0.77‹?›

🔗 View Article (PMID 12242514)

Published in J Cancer Res Clin Oncol on August 27, 2002

Authors

C Kasper1, J Zahner, H G Sayer

Author Affiliations

1: Department of Medicine II (Oncology-Hematology-Endocrinology), Friedrich-Schiller-University Jena, 07740 Jena, Germany. christoph.kasper@med.uni-jena.de

Articles by these authors

Acute toxicity and first clinical results of intensive postinduction therapy using a modified busulfan and cyclophosphamide regimen with autologous bone marrow rescue in first remission of acute myeloid leukemia. Blood (1989) 2.03

Evidence of a graft-versus-leukemia effect in chronic lymphocytic leukemia after reduced-intensity conditioning and allogeneic stem-cell transplantation: the Cooperative German Transplant Study Group. J Clin Oncol (2003) 1.86

Efficacy and toxicity of low-dose escalating donor lymphocyte infusion given after reduced intensity conditioning allograft for multiple myeloma. Leukemia (2004) 1.45

[Mobilization of stem cells by granulocyte colony-stimulating factor for the regeneration of myocardial tissue after myocardial infarction]. Dtsch Med Wochenschr (2004) 1.42

Evidence that sustained growth suppression of intestinal anaerobic bacteria reduces the risk of acute graft-versus-host disease after sibling marrow transplantation. Blood (1992) 1.16

Dynamics of BCR-ABL mRNA expression in first-line therapy of chronic myelogenous leukemia patients with imatinib or interferon alpha/ara-C. Leukemia (2003) 1.11

Activity of oxaliplatin in patients with relapsed or cisplatin-refractory germ cell cancer: a study of the German Testicular Cancer Study Group. J Clin Oncol (2002) 1.11

Early related or unrelated haematopoietic cell transplantation results in higher overall survival and leukaemia-free survival compared with conventional chemotherapy in high-risk acute myeloid leukaemia patients in first complete remission. Leukemia (2009) 1.08

Pneumocystis carinii pneumonia as a complication of bendamustine monotherapy in a patient with advanced progressive breast cancer. J Cancer Res Clin Oncol (2003) 1.04

Allogeneic stem cell transplantation after a fludarabine/busulfan-based reduced-intensity conditioning in patients with myelodysplastic syndrome or secondary acute myeloid leukemia. Ann Hematol (2003) 1.03

RGS3 and RGS4 are GTPase activating proteins in the heart. J Mol Cell Cardiol (1998) 1.02

Nonmyeloablative stem cell transplantation in adults with high-risk ALL may be effective in early but not in advanced disease. Leukemia (2002) 0.96

Combined standard graft-versus-host disease (GvHD) prophylaxis with mycophenolate mofetil (MMF) in allogeneic peripheral blood stem cell transplantation from unrelated donors. Bone Marrow Transplant (2004) 0.91

Irinotecan in patients with relapsed or cisplatin-refractory germ cell cancer: a phase II study of the German Testicular Cancer Study Group. Br J Cancer (2002) 0.88

Acute abdomen by varicella zoster virus induced gastritis after autologous peripheral blood stem cell transplantation in a patient with non-Hodgkin's lymphoma. Acta Haematol (2006) 0.86

Impact of early NK cell recovery on development of GvHD and CMV reactivation in dose-reduced regimen prior to allogeneic PBSCT. Bone Marrow Transplant (2005) 0.85

[Recurrences and metastases of cystosarcoma phylloides (phylloid tumor, WHO). On the 150th birthday of a controversial diagnostic concept]. Geburtshilfe Frauenheilkd (1989) 0.83

Filgrastim mobilization and collection of allogeneic blood progenitor cells from adult family donors: first interim report of a prospective German multicenter study. Ann Hematol (2002) 0.82

Distinct reconstitution of neutrophil functions after allogeneic peripheral blood stem cell transplantation. J Cancer Res Clin Oncol (2007) 0.78

Negative regulation of alpha2-adrenergic receptor-mediated Gi signalling by a novel pathway. Biochem J (1999) 0.78

Exanthema in Legionnaires' disease mimicking a severe cutaneous drug reaction. Clin Exp Dermatol (2009) 0.77

Treatment with granulocyte-colony stimulating factor in patients with acute myocardial infarction. Evidence for a stimulation of neovascularization and improvement of myocardial perfusion. Pharmazie (2006) 0.77

Early versus late administration of pegfilgrastim after high-dose chemotherapy and autologous hematopoietic stem cell transplantation. J Cancer Res Clin Oncol (2011) 0.77

Initial treatment of acute graft-versus-host disease with a murine monoclonal antibody directed to the human alpha/beta T cell receptor. Cancer Immunol Immunother (1991) 0.76

Dose-reduced conditioning for allografting in 44 patients with chronic myeloid leukaemia: a retrospective analysis. Br J Haematol (2001) 0.76

[Genetically engineered drugs and their application with the example of erythropoietin]. Anasthesiol Intensivmed Notfallmed Schmerzther (2001) 0.75

Very late appearance of acute graft-versus-host disease after tapering immunosuppression. J Dermatol (2001) 0.75

[The latest from basic research: mechanisms of metastasis]. Pneumologie (1996) 0.75

Bone marrow transplantation for myeloblastoma. Eur J Haematol (1988) 0.75

Six weeks of continuous intravenous cyclosporine and short-course methotrexate as prophylaxis for acute graft-versus-host disease after allogeneic bone marrow transplantation. Transplantation (1990) 0.75

Influence of treatment modality, patient/donor characteristics, and disease stage on the risk of relapse after allogeneic marrow transplantation for acute leukemia. Haematol Blood Transfus (1990) 0.75

[Radiologic diagnosis of primary extranodal lymphoma manifestations]. Radiologe (1997) 0.75

Constant intravenous pentoxifylline infusions in allogeneic marrow transplant recipients: results of a dose escalation study. Bone Marrow Transplant (1993) 0.75

[High dose chemotherapy of solid tumors]. Med Klin (Munich) (1997) 0.75

Clinical results and the Essen concept of TBI. Radiother Oncol (1990) 0.75

Correlation between granulocyte/macrophage-colony-forming units and CD34+ cells in apheresis products from patients treated with different chemotherapy regimens and granulocyte-colony-stimulating factor to mobilize peripheral blood progenitor cells. J Cancer Res Clin Oncol (1998) 0.75

[Maintenance of remission in acute myeloid leukemia by allogeneic or autologous bone marrow transplantation]. Dtsch Med Wochenschr (1991) 0.75

Results of conventional-dose cytosine arabinoside and idarubicin in elderly patients with acute myeloid leukemia. Ann Hematol (1994) 0.75